# COVID-19 and Nonalcoholic Fatty Liver Disease

> **NCT04982328** · — · COMPLETED · sponsor: **University Hospital for Infectious Diseases, Croatia** · enrollment: 120 (actual)

## Conditions studied

- Covid19
- NAFLD

## Interventions

- **DIAGNOSTIC_TEST:** Th17 cytokine profile
- **DIAGNOSTIC_TEST:** Screening for the components of metabolic syndrome
- **DIAGNOSTIC_TEST:** Evaluation of the degree of steatosis

## Key facts

- **NCT ID:** NCT04982328
- **Lead sponsor:** University Hospital for Infectious Diseases, Croatia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-15
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04982328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04982328, "COVID-19 and Nonalcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04982328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*